Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company, announced that Satyavrat “Sath” Shukla, Spero’s current Chief Financial Officer and Treasurer, will serve as Spero’s President and Chief Executive Officer (CEO), and as a member of the Board of Directors, effective August 1, 2023. Shukla will succeed Spero’s current CEO and President, Ankit Mahadevia, M.D., who…